The disproportionate growth of office-based atherectomy

Journal of Vascular Surgery

Volumn 65, Issue 2, 2017, Pages 495-500

  Mukherjee, Dipankar ^a   Hashemi, Homayoun ^a   Contos, Brian ^b  

^a Inova Fairfax Medical Campus ^*  (United States)

^b Advisory Board Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHERECTOMY; CARDIOLOGIST; CONFERENCE PAPER; COST; HOSPITAL; HOSPITAL PATIENT; LOWER LIMB; MEDICAID; MEDICARE; OUTPATIENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICIAN; POLICY; PRIORITY JOURNAL; REIMBURSEMENT; VASCULAR SURGEON; AMBULATORY CARE; AMBULATORY SURGERY; CLINICAL PRACTICE; ECONOMICS; FACTUAL DATABASE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; PERIPHERAL ARTERIAL DISEASE; TIME FACTOR; TRENDS; UNITED STATES; VASCULARIZATION; WORKLOAD;

AMBULATORY CARE; AMBULATORY SURGICAL PROCEDURES; ATHERECTOMY; DATABASES, FACTUAL; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LOWER EXTREMITY; MEDICARE; OFFICE VISITS; PERIPHERAL ARTERIAL DISEASE; PRACTICE PATTERNS, PHYSICIANS'; PROCESS ASSESSMENT (HEALTH CARE); TIME FACTORS; UNITED STATES; WORKLOAD;

EID: 85008238138     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2016.08.112     Document Type: Conference Paper

References (14)

1. 1 Goodney, P.P., Beck, A.W., Nagle, J., Welch, H.G., Zwolak, R.M., National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg 50 (2009), 54–60.
2. 2 Rowe, V.L., Lee, W., Weaver, F.A., Etzioni, D., Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. J Vasc Surg 49 (2009), 910–917.
3. 3 Department of Health and Human Services. Payment policies under the physician fee schedule and other revisions to part B for CY 2011 final rule. Federal Register 75 (2010), 73170–73860.
4. 4 Jones, W.S., Mi, X., Qualls, L.G., Vemulapalli, S., Peterson, E.D., Patel, M.R., et al. Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system. J Am Coll Cardiol 65 (2015), 920–927.
5. 5 Carr, J., Julien, W., Lee, A., Outpatient CLI revascularization in the United States. Endovascular Today 15 (2016), 86–89.
6. 6 Jain, K.M., Munn, J., Rummel, M., Vaddineni, S., Longton, C., Future of vascular surgery is in the office. J Vasc Surg 51 (2010), 509–513.
7. 7 MedTech360 Peripheral Vascular Reports for Japan, US, Europe, LATAM. 2015 Millennium Research Group, Inc. All rights reserved. Reproduction, distribution, transmission or publication is prohibited. Reprinted with permission.
8. 8 Ambler, G.K., Radwan, R., Hayes, P.D., Twine, C.P., Atherectomy for peripheral arterial disease. Cochrane Database Syst Rev, 2014, CD006680.
9. 9 McKinsey, J.F., Zeller, T., Rocha-Singh, K.J., Jaff, M.R., Garcia, L.A., Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv 7 (2014), 923–933.
10. 10 Laird, J.R., Katzen, B.T., Scheinert, D., Lammer, J., Carpenter, J., Buchbinder, M., et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther 19 (2012), 1–9.
11. 11 Garcia, L., Jaff, M.R., Metzger, C., Sedillo, G., Pershad, A., Zidar, F., et al. Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUBERB trial. Circ Cardiovasc Interv, 8, 2015, e000937.
12. 12 Matsumura, J.S., Yamanouchi, D., Goldstein, J.A., Pollock, C.W., Bosiers, M., Schultz, G.A., et al. The United States study for evaluating endovascular treatments of lesions in the superficial femoral artery and proximal popliteal by using the Protégé Everflex Nitinol Stent System II (DURABILITY II). J Vasc Surg 58 (2013), 73–83.e1.
13. 13 Gray, B.H., Diaz-Sandoval, L.J., Dieter, R.S., Jaff, M.R., White, C.J., SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use. Catheter Cardiovasc Interv 84 (2014), 539–545.
14. 14 Klein, A.J., Pinto, D.S., Gray, B.H., Jaff, M.R., White, C.J., Drachman, D.E., SCAI expert consensus statement for femoral-popliteal arterial intervention appropriate use. Catheter Cardiovasc Interv 84 (2014), 529–538.